Beta to Alpha

Share this post
Q4FY21 | Sequent Scientific Notes
betatoalpha.substack.com

Q4FY21 | Sequent Scientific Notes

Sequent 2.0

Saket Mehrotra
Jul 1, 2021
Share this post
Q4FY21 | Sequent Scientific Notes
betatoalpha.substack.com

High Level Notes

  1. India business doubled from 39 cr. to 78 cr. driven by two factors - underlying growth of existing products and commercialisation of Zoetis portfolio

  2. Company has laid out a chart for making ~200 cr. in investments in the next 2 years and renew focus on India, Turkey and Brazil

  3. An advisory board has been put into place to help the company …

Keep reading with a 7-day free trial

Subscribe to Beta to Alpha to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2022 Saket Mehrotra
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing